A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

National Cancer Institute, Bethesda

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

University of Florida, Gainesville

University of Alabama, Birmingham

St. Jude Children's Research Hospital, Memphis

Cincinnati Children's Hospital Medical Center, Cincinnati

Indiana University, Indianapolis

University of Michigan, Ann Arbor

University of Iowa Hospitals and Clinics, Iowa City

Children's Hospital Los Angeles, Los Angeles

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

UCLA/Mattel's Children's Hospital, Los Angeles

Sarcoma Oncology Center, Santa Monica

UCSF, San Francisco

Stanford University, Palo Alto

Seattle Cancer Care Alliance/University of Washington Medical Center, Seattle

University of Miami, Miami

Dana-Farber Cancer Institute, Boston